ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
ACCURAY INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 27, 2026
$0.14−0.01 (-8.16%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Accuray statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Accuray | Industry median |
|---|---|---|
| Market Cap | $17.08M | $230.55M |
| Enterprise Value | $124.33M | $202.97M |
| PS Ratio | 0.04 | 3.11 |
| PB Ratio | 0.41 | 3.14 |
Enterprise value
| Measure | Accuray | Industry median |
|---|---|---|
| EV / Sales | 0.31 | 2.92 |
Income (trailing twelve months)
| Measure | Accuray | Industry median |
|---|---|---|
| Revenue | $401.95M | $102.39M |
| Gross Profit | $111.45M | $60.36M |
| Operating Income | -$26.44M | -$4.31M |
| Pretax Income | -$47.25M | -$2.26M |
| Net Income | -$49.19M | -$6.57M |
| EBITDA | -$18.50M | -$1.98M |
Margins
| Measure | Accuray | Industry median |
|---|---|---|
| Gross Margin | 27.7% | 55.1% |
| Operating Margin | -6.58% | -6.04% |
| Pretax Margin | -11.8% | -4.11% |
| Profit Margin | -12.2% | -10.5% |
| EBITDA Margin | -4.60% | -2.67% |
| FCF Margin | -3.19% | -0.30% |
Returns
| Measure | Accuray | Industry median |
|---|---|---|
| Return on Equity (ROE) | -80.1% | -19.2% |
| Return on Assets (ROA) | -10.8% | -13.3% |
| Return on Invested Capital (ROIC) | -13.0% | -4.11% |
| Return on Capital Employed (ROCE) | -10.5% | -9.07% |
Growth
| Measure | Accuray | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -12.3% | 8.85% |
| Revenue Growth (3Y CAGR) | -3.52% | 7.08% |
| Revenue Growth (5Y CAGR) | 0.28% | 11.8% |
Balance sheet
| Measure | Accuray | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $40.62M | $37.33M |
| Total Debt | $147.87M | $72.66M |
| Net Cash (Debt) | -$107.25M | $3.92M |
| Net Cash Per Share | -$0.90 | $0.28 |
| Equity (Book Value) | $41.70M | $57.36M |
| Book Value Per Share | $0.35 | $2.81 |
| Tangible Book Value | -$16.21M | $10.71M |
| Working Capital | $96.37M | $54.64M |
Financial position
| Measure | Accuray | Industry median |
|---|---|---|
| Current Ratio | 1.50 | 2.50 |
| Quick Ratio | 0.56 | 1.54 |
| Debt / Equity | 3.55 | 0.38 |
| Interest Coverage | -0.80 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Accuray | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.98M | -$653.46K |
| Capital Expenditures | -$5.86M | -$3.69M |
| Free Cash Flow | -$12.84M | -$835.02K |
| FCF Per Share | -$0.11 | -$0.02 |
Efficiency
| Measure | Accuray | Industry median |
|---|---|---|
| Asset Turnover | 0.88 | 0.59 |
| Inventory Turnover | 2.02 | 2.21 |
| Revenue Per Employee | $496.84K | $322.57K |
| Profits Per Employee | -$60.81K | -$51.88K |
| Employee Count | 809 | 185 |
Dividends and yields
| Measure | Accuray | Industry median |
|---|---|---|
| Earnings Yield | -288.0% | -6.91% |
| FCF Yield | -75.2% | -0.56% |
| Buyback Yield | -3.89% | 0.78% |
| Shareholder Yield | -3.89% | 0.80% |
Shares
| Measure | Accuray | Industry median |
|---|---|---|
| Shares Outstanding | 119,439,000 | 44,856,700 |
| Shares Change (QoQ) | 0.43% | 0.27% |
| Float | 85,454,400 | 37,097,900 |
| Shares Held by Insiders | 28.5% | 10.6% |
| Shares Held by Institutions | 59.9% | 63.5% |
Taxes
| Measure | Accuray | Industry median |
|---|---|---|
| Income Tax | $1.95M | $1.52M |
Scores
| Measure | Accuray | Industry median |
|---|---|---|
| Altman Z-Score | -0.80 | 1.95 |
| Piotroski F-Score | 1 | 5 |
| Beneish M-Score | -3.06 | -2.64 |
Calculated by StockData from Accuray's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.